SCHEMBL22553976

SCHEMBL22553976

Cn1nc(Br)c2cc(Cl)cnc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.42
HPGD P15428 2/20 0.42
HTT P42858 2/20 0.42
KMT2A Q03164 3/20 0.41
LMNA P02545 2/20 0.41
MEN1 O00255 1/20 0.41
PABPC1 P11940 1/20 0.41
NR3C1 P04150 3/20 0.39
GSK3B P49841 1/20 0.36
HRH4 Q9H3N8 4/20 0.35
HRH3 Q9Y5N1 2/20 0.33
MAPT P10636 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
KDM4E B2RXH2 1/20 0.32
KDM4A O75164 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30731155 1.00 HSD17B10 (0.42) HSD17B10HPGDHTTKMT2ALMNA
SCHEMBL14788359 0.80 SPR (0.46) HSD17B10HPGDHTTKMT2ALMNA
SCHEMBL31167133 0.79 GSK3B (0.58) HSD17B10HPGDHTTKMT2ALMNA
SCHEMBL16199065 0.79 HPGD (0.46) HSD17B10HPGDHTTKMT2ALMNA
SCHEMBL18538040 0.76 HPGD (0.40) HSD17B10HPGDHTTKMT2ALMNA
SCHEMBL27284675 0.73 PDE10A (0.30)
SCHEMBL22553853 0.72 HSD17B10 (0.37) HSD17B10HPGDHTTKMT2ALMNA
SCHEMBL26630387 0.72 MAPT (0.43) HTTKMT2AMEN1MAPTL3MBTL1
SCHEMBL31149372 0.71 HSD17B10 (0.42) HSD17B10HPGDHTTKMT2ALMNA
SCHEMBL15384517 0.71 HSD17B10 (0.42) HSD17B10HPGDHTTKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors HIBERCELL, INC. (US) 2024-03-05 US disclosed
CN-112088157-B Aryl-bipyridylamine derivatives as phosphatidylinositol phosphokinase inhibitors 拉文纳制药公司 2023-12-26 CN disclosed
CN-112088157-A Aryl-bipyridine amine derivatives as phosphoinositide kinase inhibitors 拉文纳制药公司 2020-12-15 CN disclosed
EP-3728230-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS Ravenna Pharmaceuticals, Inc. (US) 2020-10-28 EP disclosed
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2020-10-22 US disclosed
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2020-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS PIP5K1A, PIP5K1B, PIP5K1C HSD17B10 3839/4885HPGD 3902/4885HTT 1981/4885
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors PIP5K1A, PIP5K1B, PIP5K1C HSD17B10 3839/4885HPGD 3902/4885HTT 1981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.